Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Dopa in Retinitis Pigmentosa
NCT02837640Phase 2Unknown
- Sponsor
- Beirut Eye Specialist Hospital
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa + carbidopa in retinitis pigmentosa (RP), sponsored by Beirut Eye Specialist Hospital. Status: unknown.
02
Drugs
levodopa + carbidopa
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT02837640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02837640.